Shore Capital Launches Agentis Longevity to Revolutionize Aging
Slice of Healthcare Team
Dec 20, 2024
Key Highlights
- Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector.
- Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine Solutions and AlliRx.
- Focus areas include hormone optimization, stem cells, and precision health testing.
- Supported by a world-class board with experts in healthcare innovation and longevity medicine.
- Backed by Shore Capital’s resources and operational expertise.
Source: Business Wire
Notable Quotes
“ The longevity marketplace is primed for bold leadership, and I am inspired by the opportunity to help people live a life of wellness while addressing unmet needs in healthcare. ”
Jimmy St Louis, CEO at Agentis Longevity
“ We’ve found that American consumers are increasingly motivated to prioritize proactively managing their health, and we are excited to announce another Shore platform investment aligned with the growing theme of consumerization in healthcare. ”
Logan Pitts, Vice President at Shore Capital
“ The early-stage growth of the consumer longevity market presents an opportunity to become a national leader by combining cutting-edge services and products with robust clinical practices and education. ”
Chris Mioton, Partner at Shore Capital
SoHC's Take
Agentis Longevity Shore Capital Partners Jimmy St Louis
